The Karolinska University Hospital is a teaching hospital affiliated with Karolinska Institutet in Stockholm, Sweden, with two major sites in the municipalities of Solna and Huddinge. The hospital network is the second largest in Sweden, after Sahlgrenska University Hospital.

There are 1,340 beds in Karolinska University Hospital, Dept of Paediatric Oncology and Haematology.

During the past decade, Karolinska University Hospital, Dept of Paediatric Oncology and Haematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karolinska University Hospital, Dept of Paediatric Oncology and Haematology" #1 collaborator was "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator, "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Karolinska University Hospital, Dept of Paediatric Oncology and Haematology" are "Leukemia, Acute Lymphoblastic" (2 trials). Many other conditions were trialed in "Karolinska University Hospital, Dept of Paediatric Oncology and Haematology" in a lesser frequency.

Most popular intervention types in "Karolinska University Hospital, Dept of Paediatric Oncology and Haematology" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Blinatumomab" (1 trials), "Imatinib" (1 trials), "Inotuzumab Ozogamicin+Standard Maintenance Therapy" (1 trials) and "Observational" (1 trials). Other intervention names were less common.

The vast majority of trials in "Karolinska University Hospital, Dept of Paediatric Oncology and Haematology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Karolinska University Hospital, Dept of Paediatric Oncology and Haematology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Karolinska University Hospital, Dept of Paediatric Oncology and Haematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karolinska University Hospital, Dept of Paediatric Oncology and Haematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".